Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience

BACKGROUND: Treatment with radium-223 has been shown to increase survival and to delay skeletal events related to bone metastases of patients with metastatic Castration Resistant Prostate Cancer (mCRPC). This treatment has also proved to be well tolerated, and hematological toxicity, in particular a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Prostate Int
Autori principali: Costa, Renato P., Bordonaro, Sebastiano, Cappuccio, Francesco, Tripoli, Vincenzo, Murabito, Alessandra, Licari, Maria, Valerio, Maria R., Tralongo, Paolo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Asian Pacific Prostate Society 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6424691/
https://ncbi.nlm.nih.gov/pubmed/30937295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prnil.2018.08.001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi